![Evaluation of the Effect of Diabetes on Rheumatoid Arthritis–related Outcomes in an Electronic Health Record–based Rheumatology Registry | The Journal of Rheumatology Evaluation of the Effect of Diabetes on Rheumatoid Arthritis–related Outcomes in an Electronic Health Record–based Rheumatology Registry | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/48/7/992/F2.large.jpg)
Evaluation of the Effect of Diabetes on Rheumatoid Arthritis–related Outcomes in an Electronic Health Record–based Rheumatology Registry | The Journal of Rheumatology
![PDF) B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: A longitudinal observational study on 120 patients PDF) B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: A longitudinal observational study on 120 patients](https://i1.rgstatic.net/publication/317067565_B_cell_repopulation_kinetics_after_rituximab_treatment_in_ANCA-associated_vasculitides_compared_to_rheumatoid_arthritis_and_connective_tissue_diseases_A_longitudinal_observational_study_on_120_patient/links/595f4c3b458515a35790f41b/largepreview.png)
PDF) B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: A longitudinal observational study on 120 patients
![JCM | Free Full-Text | Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD) JCM | Free Full-Text | Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)](https://www.mdpi.com/jcm/jcm-10-03806/article_deploy/html/images/jcm-10-03806-g007.png)
JCM | Free Full-Text | Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)
![Evaluation of the Effect of Diabetes on Rheumatoid Arthritis–related Outcomes in an Electronic Health Record–based Rheumatology Registry | The Journal of Rheumatology Evaluation of the Effect of Diabetes on Rheumatoid Arthritis–related Outcomes in an Electronic Health Record–based Rheumatology Registry | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/48/7/992/F1.large.jpg)
Evaluation of the Effect of Diabetes on Rheumatoid Arthritis–related Outcomes in an Electronic Health Record–based Rheumatology Registry | The Journal of Rheumatology
![PDF] Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs | Semantic Scholar PDF] Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b34f5bcb81313ab234661e472ccfd715122483e4/11-Table6-1.png)
PDF] Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs | Semantic Scholar
![PDF) The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: Clues for the optimization of rituximab treatment strategies PDF) The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: Clues for the optimization of rituximab treatment strategies](https://i1.rgstatic.net/publication/46218276_The_Belgian_MIRA_MabThera_In_Rheumatoid_Arthritis_registry_Clues_for_the_optimization_of_rituximab_treatment_strategies/links/02e7e528dc6ee9cf51000000/largepreview.png)
PDF) The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: Clues for the optimization of rituximab treatment strategies
![PDF) CXCL13: A novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis PDF) CXCL13: A novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis](https://i1.rgstatic.net/publication/49629720_CXCL13_A_novel_biomarker_of_B-cell_return_following_rituximab_treatment_and_synovitis_in_patients_with_rheumatoid_arthritis/links/561e5c9108aecade1acc0b75/largepreview.png)
PDF) CXCL13: A novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis
![Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease | Request PDF Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease | Request PDF](https://www.researchgate.net/publication/360802889/figure/fig2/AS:11431281082777621@1662169853785/Drug-induced-liver-injury-DILI-The-size-and-the-distance-from-the-center-represent-the_Q320.jpg)
Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease | Request PDF
![In Vitro Effects of Rituximab on the Proliferation, Activation and Differentiation of Human B Cells - American Journal of Transplantation In Vitro Effects of Rituximab on the Proliferation, Activation and Differentiation of Human B Cells - American Journal of Transplantation](https://www.amjtransplant.org/cms/attachment/c68ec0b6-b800-4e59-bb28-fce329867250/gr1_lrg.jpg)
In Vitro Effects of Rituximab on the Proliferation, Activation and Differentiation of Human B Cells - American Journal of Transplantation
![JCM | Free Full-Text | Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD) JCM | Free Full-Text | Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)](https://pub.mdpi-res.com/jcm/jcm-10-03806/article_deploy/html/images/jcm-10-03806-g001.png?1629974482)
JCM | Free Full-Text | Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)
![Frontiers | Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment Frontiers | Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment](https://www.frontiersin.org/files/Articles/494836/fmed-06-00238-HTML/image_m/fmed-06-00238-g001.jpg)
Frontiers | Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment
![JCM | Free Full-Text | Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review JCM | Free Full-Text | Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review](https://www.mdpi.com/jcm/jcm-09-03070/article_deploy/html/images/jcm-09-03070-g001.png)
JCM | Free Full-Text | Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review
Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases
![Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study | The Journal of Rheumatology Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/43/5/869/F1.large.jpg)
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study | The Journal of Rheumatology
Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the Auto
![PDF) THU0120 Long-term safety of rituximab: 10-year follow-up in the rheumatoid arthritis global clinical trial programme PDF) THU0120 Long-term safety of rituximab: 10-year follow-up in the rheumatoid arthritis global clinical trial programme](https://i1.rgstatic.net/publication/271000387_THU0120_Long-term_safety_of_rituximab_10-year_follow-up_in_the_rheumatoid_arthritis_global_clinical_trial_programme/links/55d7605708aed6a199a68259/largepreview.png)
PDF) THU0120 Long-term safety of rituximab: 10-year follow-up in the rheumatoid arthritis global clinical trial programme
![Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease | SpringerLink Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00296-022-05143-y/MediaObjects/296_2022_5143_Fig2_HTML.png)
Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease | SpringerLink
![Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis](https://becarispublishing.com/cms/10.2217/cer-2017-0106/asset/2dda277b-f91a-4a04-9108-31fc84da2970/assets/images/large/figure2.jpg)
Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritis
![New Onset of Psoriasis in a Patient with Rheumatoid Arthritis Treated with Rituximab | The Journal of Rheumatology New Onset of Psoriasis in a Patient with Rheumatoid Arthritis Treated with Rituximab | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/40/7/1230/F1.large.jpg?width=800&height=600&carousel=1)